Ken Fisher Dr Reddys Laboratories LTD Transaction History

Fisher Asset Management, LLC

$213 Billion
Q1 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Fisher Asset Management, LLC holds 318,355 shares of RDY stock, worth $24.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

318,355

Previous 205,280 55.08%

Holding current value

$24.3 Million

Previous $14.3 Million 63.49%

% of portfolio

0.01%

Previous 0.01%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$67.36 - $77.59 $7.62 Million - $8.77 Million	113,075 Added 55.08%	318,355 $23.4 Million
Q4 2023 Mar 05, 2024	BUY	$64.27 - $69.9 $39,076 - $42,499	608 Added 0.3%	205,280 $14.3 Million
Q4 2023 Feb 06, 2024	BUY	$64.27 - $69.9 $7.33 Million - $7.97 Million	114,022 Added 125.78%	204,672 $14.2 Million
Q3 2023 Nov 13, 2023	BUY	$61.9 - $72.77 $5.61 Million - $6.6 Million	90,650 New	90,650 $6.06 Million
Q2 2018 Jul 09, 2018	SELL	$28.49 - $35.06 $144 Million - $177 Million	-5,055,686 Closed	0 $0

Q1 2018 May 11, 2018	SELL	$31.93 - $39.54 $13.7 Million - $17 Million	-430,134 Reduced 7.84%	5,055,686 $165 Million
Q1 2018 Apr 19, 2018	BUY	$31.93 - $39.54 $2.26 Million - $2.8 Million	70,803 Added 1.31%	5,485,820 $179 Million
Q4 2017 Jan 24, 2018	SELL	$34.15 - $37.62 $1.82 Million - $2 Million	-53,275 Reduced 0.97%	5,415,017 $203 Million
Q3 2017 Oct 17, 2017	BUY	$30.11 - $37.72 $165 Million - $206 Million	5,468,292	5,468,292 $195 Million

Others Institutions Holding RDY

# of Institutions

242

Shares Held

23.6M

Call Options Held

25.2K

Put Options Held

8.5K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $12.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account